Cargando…

Effects of Tumour Necrosis Factor Antagonists on Insulin Sensitivity/Resistance in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis

OBJECTIVE: Beyond the joints, TNFi (tumour necrosis factor inhibitor) therapy may confer systemic benefits in rheumatoid arthritis (RA). Several studies have investigated the role of TNFi on insulin resistance/sensitivity (IR/IS). This question is of general interest given the emerging evidence link...

Descripción completa

Detalles Bibliográficos
Autores principales:	Burska, Agata N., Sakthiswary, Rajalingham, Sattar, Naveed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4482317/ https://www.ncbi.nlm.nih.gov/pubmed/26110878 http://dx.doi.org/10.1371/journal.pone.0128889

Ejemplares similares

Predictors of diastolic dysfunction in rheumatoid arthritis
por: Sakthiswary, Rajalingham, et al.
Publicado: (2015)

Rheumatoid Arthritis: Refractory to Infliximab, a Tumor Necrosis Factor Inhibitor
por: Solehan, Hana Maizuliana bt, et al.
Publicado: (2011)

The Clinical Significance of Interleukin–1 Receptor Antagonist +2018 Polymorphism in Rheumatoid Arthritis
por: Ismail, Endom, et al.
Publicado: (2016)

Predictors of frequent oral analgesic use in rheumatoid arthritis
por: Gupta, Esha das, et al.
Publicado: (2014)

Frequency and Clinical Significance of Elevated IgG4 in Rheumatoid Arthritis: A Systematic Review
por: Sakthiswary, Rajalingham, et al.
Publicado: (2022)

Pathomechanisms of bone loss in rheumatoid arthritis
por: Sakthiswary, Rajalingham, et al.
Publicado: (2022)

Cytokines as Biomarkers in Rheumatoid Arthritis
por: Burska, Agata, et al.
Publicado: (2014)

Effects of Methotrexate Therapy on the Levels of Gonadotropic Hormones in Rheumatoid Arthritis Patients of Reproductive Age
por: Kyaw, Min Tun, et al.
Publicado: (2020)

Methotrexate-Associated Nonalcoholic Fatty Liver Disease with Transaminitis in Rheumatoid Arthritis
por: Sakthiswary, Rajalingham, et al.
Publicado: (2014)

Intravenous Immunoglobulin in the Therapeutic Armamentarium of Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis
por: Sakthiswary, Rajalingham, et al.
Publicado: (2014)

Decoding the Clinical Significance of Immunoglobulin G4 in Rheumatoid Arthritis
por: Tan, Li Fen, et al.
Publicado: (2023)

Anti-tumour necrosis factor alpha therapy improves insulin sensitivity in normal-weight but not in obese patients with rheumatoid arthritis
por: Stavropoulos-Kalinoglou, Antonios, et al.
Publicado: (2012)

The Clinical Significance of Vitamin D in Systemic Lupus Erythematosus: A Systematic Review
por: Sakthiswary, Rajalingham, et al.
Publicado: (2013)

Heterogeneity in Comparisons of Discontinuation of Tumor Necrosis Factor Antagonists in Rheumatoid Arthritis - A Meta-Analysis
por: Fisher, Anat, et al.
Publicado: (2016)

Personal Protective Equipment (PPE) and Its Use in COVID-19: Important Facts
por: Das, Srijit, et al.
Publicado: (2020)

Correction: Heterogeneity in Comparisons of Discontinuation of Tumor Necrosis Factor Antagonists in Rheumatoid Arthritis—A Meta-Analysis
por: Fisher, Anat, et al.
Publicado: (2017)

Chronic necrotizing pulmonary aspergillosis presenting as bilateral pleural effusion: a case report
por: Rajalingham, Sakthiswary, et al.
Publicado: (2012)

Stem cell therapy in neurodegenerative diseases: From principles to practice
por: Sakthiswary, Rajalingham, et al.
Publicado: (2012)

Comparison of drug survival rates for tumor necrosis factor antagonists in rheumatoid arthritis
por: Martínez-Santana, Virginia, et al.
Publicado: (2013)

Anti-tumour necrosis factor therapy and B cells in rheumatoid arthritis
por: Leandro, Maria J
Publicado: (2009)

Synovial Tissue Heterogeneity in Rheumatoid Arthritis and Changes With Biologic and Targeted Synthetic Therapies to Inform Stratified Therapy
por: Ouboussad, Lylia, et al.
Publicado: (2019)

Autoantibodies to Posttranslational Modifications in Rheumatoid Arthritis
por: Burska, Agata N., et al.
Publicado: (2014)

Sinus aspergilloma in rheumatoid arthritis before or during tumor necrosis factor-alpha antagonist therapy
por: Leboime, Ariane, et al.
Publicado: (2009)

Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis
por: Glossop, John R, et al.
Publicado: (2005)

Effect of IL-6 receptor blockade on high-sensitivity troponin T and NT-proBNP in rheumatoid arthritis
por: Welsh, Paul, et al.
Publicado: (2016)

Modulation of peripheral T-cell function by interleukin-7 in rheumatoid arthritis
por: Churchman, Sarah M, et al.
Publicado: (2014)

Anti-tumor necrosis factor therapy improves insulin resistance, beta cell function and insulin signaling in active rheumatoid arthritis patients with high insulin resistance
por: Stagakis, Ilias, et al.
Publicado: (2012)

Synovial expression of IL-15 in rheumatoid arthritis is not influenced by blockade of tumour necrosis factor
por: Ernestam, Sofia, et al.
Publicado: (2006)

The comparative effectiveness of abatacept versus anti-tumour necrosis factor switching for rheumatoid arthritis patients previously treated with an anti-tumour necrosis factor
por: Harrold, Leslie R, et al.
Publicado: (2015)

Anti- and non-tumor necrosis factor-α-targeted therapies effects on insulin resistance in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis
por: Wang, Chrong-Reen, et al.
Publicado: (2021)

Etanercept in the treatment of recalcitrant enteropathic arthritis: a case report
por: Mohamed Said, Mohd Shahrir, et al.
Publicado: (2012)

Risk factors for symptomatic Avascular Necrosis (AVN) in a multi-ethnic Systemic Lupus Erythematosus (SLE) cohort
por: Shaharir, Syahrul Sazliyana, et al.
Publicado: (2021)

Antinuclear antibodies in primary osteoarthritis of the knee: a case-control study
por: Sakthiswary, Rajalingham, et al.
Publicado: (2012)

Beyond the joints in rheumatoid arthritis: Effects of adalimumab on hematologic and lipid indices
por: Sakthiswary, R., et al.
Publicado: (2012)

Anti-tumour necrosis factor therapy modulates the OPG/OPGL system in rheumatoid arthritis synovium
por: Catrina, AI, et al.
Publicado: (2004)

Genome-wide association study of response to tumour necrosis factor inhibitor therapy in rheumatoid arthritis
por: Massey, Jonathan, et al.
Publicado: (2018)

The risk of cancer in patients with rheumatoid arthritis taking tumor necrosis factor antagonists: a nationwide cohort study
por: Wu, Chun-Ying, et al.
Publicado: (2014)

Impact of switching between reference biologics and biosimilars of tumour necrosis factor inhibitors for rheumatoid arthritis: a systematic review and network meta-analysis
por: de Oliveira Ascef, Bruna, et al.
Publicado: (2023)

Aminotransferases are associated with insulin resistance and atherosclerosis in rheumatoid arthritis
por: Dessein, Patrick H, et al.
Publicado: (2007)

Magnesium supplementation and insulin resistance in patients with rheumatoid arthritis
por: Norouzi, Mohsen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_okqaa7ukgd6l6amij97s3b5teh